$227.44
▲ +$2.72
(+1.21%)
Vol 136K
Mkt Cap
$32.7B
P/E
22.0
ROE
24.8%
Margin
27.5%
Beta
0.92
Div Yield
1.07%
52W
$202–$294
Wall Street Consensus
25 analysts · Apr 20264
Strong Buy
11
Buy
9
Hold
0
Sell
1
Strong Sell
60.0%
Buy Rating
Price Chart
Similar Stocks
BSX
Boston Scientific Corp
P/E 32.7
$94.9B
IDXX
IDEXX Laboratories Inc
P/E 52.6
$54.0B
EW
Edwards Lifesciences Corp
P/E 42.3
$45.4B
BDX
Becton Dickinson and Co
P/E 25.1
$44.1B
GEHC
GE Healthcare Technologies Inc
P/E 16.9
$37.4B
DXCM
Dexcom Inc
P/E 35.9
$25.9B
ZBH
Zimmer Biomet Holdings, Inc
P/E 26.7
$18.8B
PODD
Insulet Corp
P/E 81.2
$20.0B
PEN
Penumbra Inc
P/E 73.4
$13.0B
GMED
Globus Medical Inc
P/E 23.7
$12.8B
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $2.75 | $2.81 | +$0.06 |
| Sep 2025 | $2.58 | $2.55 | $-0.03 |
| Jun 2025 | $2.51 | $2.55 | +$0.04 |
| Mar 2025 | $2.38 | $2.37 | $-0.01 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $1.3B | $1.3B | $1.3B | $1.3B | $1.4B |
| Net Income | — | $344.6M | $365.0M | $379.7M | $348.5M | $392.6M |
Fundamentals Trend
| Metric | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 24.8% | 24.8% |
| P/E (TTM) | 22.44 | 22.01 |
| Net Margin | 27.5% | 27.5% |
| Gross Margin | 60.9% | 60.9% |
| D/E Ratio | — | — |
| Current Ratio | 3.06 | 3.06 |
Key Ratios
ROA (TTM)
18.3%
P/S (TTM)
6.06
P/B
6.3
EPS (TTM)
$10.12
CF/Share
$7.33
Rev Growth 3Y
+12.9%
52W High
$293.81
52W Low
$202.00
$202.00
52-Week Range
$293.81
Financial Health
Free Cash Flow
$305.2M
Net Debt
-$569.3M
Cash
$1.4B
Total Debt
$847.7M
As of Dec 31, 2025
How does RMD compare to Health Care peers?
Peer group: Peers · Health Care (Peers) · 10 companies
RMD valuation vs Health Care peers
P/E ratio
22.4
▼
15%
below
peers
(26.3)
vs Peers
vs Industry
Undervalued
P/S ratio
6.2
▲
25%
above
peers
(4.9)
vs Peers
vs Industry
Overvalued
P/B ratio
6.3
▲
20%
above
peers
(5.3)
vs Peers
vs Industry
Pricier
Div yield
1.1%
▲
0%
above
peers
(1.1%)
vs Peers
vs Industry
Low yield
RMD profitability vs Health Care peers
ROE
24.8%
▲
57%
above
peers
(15.9%)
vs Peers
vs Industry
Top tier
Net margin
27.5%
▲
101%
above
peers
(13.7%)
vs Peers
vs Industry
Top tier
Gross margin
60.9%
▼
1%
below
peers
(61.3%)
vs Peers
vs Industry
In line
ROA
18.3%
▲
102%
above
peers
(9.0%)
vs Peers
vs Industry
Top tier
RMD financial health vs Health Care peers
D/E ratio
—
▼
0%
below
peers
(82.5)
vs Peers
vs Industry
In line
Current ratio
3.1
▲
72%
above
peers
(1.8)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
▼
5%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
RMD fundamentals radar
RMD
Peer median
Industry
RMD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RMD vs peers: key metrics
Insider Activity
BearishBuys
0
Sells
10
$5966524
FARRELL MICHAEL J
Chief Executive Officer · Apr 07
sale
4991 shs
FARRELL MICHAEL J
Chief Executive Officer · Apr 07
conversion of exercise of derivative security
4991 shs
SANDERCOCK BRETT
Chief Financial Officer · Apr 01
sale
1000 shs
FARRELL PETER CRAIG
Director · Apr 01
sale
2000 shs
FARRELL MICHAEL J
Chief Executive Officer · Mar 09
sale
4991 shs
FARRELL MICHAEL J
Chief Executive Officer · Mar 09
conversion of exercise of derivative security
4991 shs
FARRELL PETER CRAIG
Director · Mar 04
sale
2000 shs
SANDERCOCK BRETT
Chief Financial Officer · Mar 02
sale
1000 shs
FARRELL MICHAEL J
Chief Executive Officer · Feb 09
sale
4991 shs
FARRELL MICHAEL J
Chief Executive Officer · Feb 09
conversion of exercise of derivative security
4991 shs
Last 90 days
Top Holders
Top 5: 32.3%Vanguard Group Inc
12.96%
$4.3B
Blackrock Inc.
8.48%
$2.8B
State Street Corporation
4.55%
$1.5B
Bank Of New York Mellon Cor…
3.36%
$1.1B
Geode Capital Management, L…
2.95%
$984.8M
As of Dec 31, 2025
Dividends
$2.33
/ year
Feb 12, 2026
$0.6000
Nov 13, 2025
$0.6000
Aug 14, 2025
$0.6000
May 08, 2025
$0.5300
Feb 13, 2025
$0.5300
Nov 07, 2024
$0.5300
Aug 15, 2024
$0.5300
May 08, 2024
$0.4800